PDCD1 and neoplasm: In the same context, Krueger et al. assessed HCQ’s potential influence on tumor dynamics, finding that the administration of HCQ in vivo inhibited PD-L1 expression on tumor cells, leading to a pronounced reduction in the effectiveness of anti-PD-1 therapy [155].